English
Pelvic Organ Prolapse (POP) is a major medical issue for women. It is estimated that 1 in 10 women will undergo a surgery to treat POP during her lifetime. To provide mechanical support to the slipping organ, strong and stiff synthetic meshes have been used. Transvaginal meshes have been recently withdrawn from the market in many countries due to high complication rates and multiple lawsuits. Hence, there is a strong medical and societal need for breakthrough innovations. We propose a new paradigm targeting the fundamental problem of synthetic meshes, i.e., the foreign body reaction, by providing a completely biological and tissue-engineered graft to treat POP. Our strategy is based on a unique, human biological material: the Cell-Assembled extracellular Matrix (CAM). Robust CAM sheets can be assembled to create multilayered CAM sheet-based grafts or can be cut to produce yarn subsequently knitted into meshes. The performance of both solutions should be compared to treat POP because they offer an unprecedented potential for tissue regeneration combined with the ability to design and engineer the strength of the tissue at will. The goals of this project are to: 1) design human and ovine CAM sheet-based grafts and CAM knitted meshes with clinically relevant mechanical properties, and 2) evaluate the in vivo performance of both CAM sheet-based grafts and CAM knitted meshes in an allogenic model (i.e., ovine in ovine), which mimics the allogenic clinical context. This project will deliver unambiguous experimental evidence demonstrating the safety and initial efficacy of non-living, CAM-based, tissue-engineered grafts. This will take an innovative surgical solution to treat POP one step closer to clinical trials.
